A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies
Zhiwei Liu(Sun Yat-sen University), Minjia Tan(Chinese Academy of Sciences), Shangwen Jiang(Chinese Academy of Sciences), Yingluo Liu(Chinese Academy of Sciences), Jun Xu(Harvard University), Linhui Zhai(Chinese Academy of Sciences), Fuchu He(Beijing University of Technology), Jing Li(Shanghai Jiao Tong University), Xiaomin Wang(University of Science and Technology of China), Min Huang(Chinese Academy of Sciences), Lili Qian(Chinese Academy of Sciences), Yuehong Chen(Southern Medical University), Xiameng Gai(Nanchang University), Shu Ye(Chinese Academy of Sciences), Congying Pu(China Executive Leadership Academy Pudong)
Cited by 55
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Hydrothermal deposition of antimony selenosulfide thin films enables solar cells with 10% efficiency
|Nature Energy|2020|563
Cyclin B1/Cdk1 Coordinates Mitochondrial Respiration for Cell-Cycle G2/M Progression
|Developmental Cell|2014|389